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Abstract
Background: To understand the molecular mechanism of host responses to highly pathogenic avian influenza
virus infection and to get an insight into the means through which virus overcomes host defense mechanism, we
studied global gene expression response of human lung carcinoma cells (A549) at early and late stages of infection
with highly pathogenic avian Influenza A (H5N1) virus and compared it with a reverse genetics modified
recombinant A (H5N1) vaccine virus using microarray platform.
Results: The response was studied at time points 4, 8, 16 and 24 hours post infection (hpi). Gene ontology analysis
revealed that the genes affected by both the viruses were qualitatively similar but quantitatively different.
Significant differences were observed in the expression of genes involved in apoptosis and immune responses,
specifically at 16 hpi.
Conclusion: We conclude that subtle differences in the ability to induce specific host responses like apoptotic
mechanism and immune responses make the highly pathogenic viruses more virulent.
Background
Outbreaks of avian influenza A (H5N1) virus, a highly
pathogenic avian influenza (HPAI), are considered as a
public health risk with pandemic potential [1]. Under-
standing the pathology, transmission, clinical features and
treatments has become necessary for the prevention and
management of such outbreaks [2,3]. The mechanisms
responsible for the virulence of HPAI viruses in humans
are not completely understood. Viral factors are necessary
for productive infection but are not sufficient to explain
the pathogenesis of HPAI infection in humans [4,5].
It is well recognized that host immunological and
genetic factors also play an important role in the patho-
genesis of H5N1 viruses in humans [5,6]. Recent studies
have shown that the high fatality rate of avian influenza
virus infections is a consequence of the complex interac-
tion of virus and host immune responses which include
overactive inflammatory response in the form of hypercy-
tokinemia (cytokine storm), that is initiated inside the
infected cells or tissue in response to virus replication
resulting in excessive cellular apoptosis and tissue
damage [7-9]. In vitro, in vivo and clinical studies have
suggested that H5N1 viruses are very strong inducers of
various cytokines and chemokines [Tumor Necrosis Fac-
tor (TNF)-alpha, Interferon (IFN)-gamma, IFN-alpha/
beta, Interleukin (IL)-6, IL-1, MIP-1 (Macrophage
Inflammatory Protein), MIG (Monokine Induced by IFN-
gamma), IP-10 (Interferon-gamma-Inducible Protein),
MCP-1 (Monocyte Chemoattractant Protein), RANTES
(Regulated on Activation Normal T-cell Expressed and
Secreted), IL-8], in both humans and animals [10-12].
However, it has also been reported that preventing cyto-
kine response doesn’t prevent H5N1 infection and cell
death [13]. Hence, further studies are needed to under-
stand the pathogenesis of H5N1 virus infection.
Alveolar epithelial cells and macrophages are the key
targets for H5N1 virus in the lungs [14]. Using infection
in human lung carcinoma cells we analyzed early and
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tion by employing gene expression profiling on a micro-
array platform. A comparative analysis was thus carried
out at different time points post infection between
highly pathogenic avian influenza A H5N1 virus (HPAI-
H5N1), A/Chicken/India/WB-NIV2664/2008(H5N1) and
modified recombinant vaccine virus (RG modified
H5N1), A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7.
A/Chicken/India/WB-NIV2664/2008 is a recent strain of
H5N1 of clade 2.2 circulating in chicken population in
India [15] and A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7
is a reverse genetics modified virus generated from HPAI,
A/chicken/India/NIV33487/2006 (H5N1) of the same clade
[16]. The objective was to understand the host responses at
different stages of virus infection at cellular level, which
could provide some insight into the biology of virus-host
interaction leading to the explanation that how virus infec-
tion modulates host cellular environment in A549 cells.
Materials and methods
Viruses
Avian Influenza A (H5N1) virus, A/Chicken/India/WB-
NIV2664/2008 (WB-NIV2664) isolated from West Bengal
(India) outbreak in 2008 [15] and reverse genetics modi-
fied H5N1 vaccine virus A/India/NIV/2006(H5N1)-PR8-
IBCDC-RG7 (IBCDC-RG7) were used in this study. The
vaccine virus was constructed using modified hemaggluti-
nin (HA) (deleting multiple basic amino acids at the clea-
vage site of HA) and neuraminidase (NA) of A/Chicken/
India/NIV33487/06 (H5N1) in the background of A/PR/8/
34 (H1N1) using reverse genetics technology at the Mole-
cular Virology and Vaccine Laboratory, Influenza Division,
Centers for Disease Control and Prevention, Atlanta.
World Health Organization (WHO) has identified this
strain as a H5N1 vaccine virus [16].
Cell line
Human lung carcinoma (A549) cells were maintained in
Dulbecco’s modified Eagle’s tissue culture medium (Invi-
trogen Life Technologies, Carlsbad, CA, USA) contain-
ing 10% fetal calf serum, 100units/ml penicillin, 100
units/ml streptomycin in tissue culture flasks (Corning,
USA) at 37°C in a CO2 incubator.
Virus infection
Monolayers of A549 cells at a concentration of 3 × 10
6
cells/ml were infected with the viruses at a multiplicity of
infection (MOI) of 3. After 1 hour the inoculum was
removed; the cells were washed twice with phosphate buf-
fer saline (PBS) and supplemented with growth media. For
each virus four different sets of tissue culture flask were
infected and harvested at four different time points. Mock
infected cells at each time point served as controls. Infec-
tion of H5N1 viruses was performed in BSL-3+ facility.
Preparation of Total Cellular RNA and microarray
Hybridization
Total RNA was extracted from the control and infected
cells at 4, 8, 16 and 24 hpi using Trizol reagent (Invitro-
gen Life Technologies, Carlsbad, CA, USA) and purified
by the RNeasy kit (Qiagen, Germany) following standard
methodology. Amplification of RNA and indirect labeling
of Cy-dye was done by Amino Allyl MessageAmp II
aRNA amplification kit (Ambion, Austin, TX, USA)
using manufacturer’s instruction. One hundred nano-
grams of RNA from control and infected cells were used
for the experiments. The RNA was reverse transcribed
and amplified according to the manufacturer’sp r o t o c o l .
The purified amino allyl aRNA was labeled with Cy3 and
Cy5 (Amersham Biosciences, USA) for control and
experimental samples respectively. Purified samples were
lyophilized, resuspended in hybridization buffer (Pronto
Universal Hybridization kit, Corning, USA) and hybri-
dized on the Discover human chip (Arrayit Corporation,
Sunnyvale, CA). Hybridization was carried out in a Hyb-
station (Genomic Solutions, Ann Arbor, MI) and the
conditions used were 55°C for 6 h, 50°C for 6 h, and 42°C
for 6 h. Scanning was performed at 5-mm resolutions
with the Scan array express (PerkinElmer, Waltham, MI).
Grid alignment was done using gene annotation files and
raw data were extracted into MS EXCEL.
Data Analysis
Data was analyzed using GENOWIZ Microarray and
Pathway analysis tool (Ocimum Biosolutions, Hyderabad,
India). Replicated values for genes were merged and
median values of the expression ratios were considered
for the dataset (2 slides per time point were used). Empty
spots were removed by filtering. Dye bias was dealt with
by applying loess normalization. Log transformation
(log2) was done to stabilize the variation in dataset and
median centering was performed to bring down data dis-
tribution of dataset close to zero. In order to detect
highly expressed genes, fold change analysis was done.
Genes with 1.5 folds up/down-regulation were consid-
ered as differentially expressed at a p-value < 0.05,
Student’s t-test. Functional classification of the genes was
performed using gene ontology and pathway analysis.
Quantitative RT-PCR analysis of host genes using SYBR
Green I
The differential expression data was validated by quanti-
tative RT-PCR. One hundred nanograms of total RNA
from control and infected A549 cells were used for
quantitative RT-PCR analysis. Reaction was performed
using the QuantiTect SYBR Green RT-PCR kit (Qiagen,
Germany) according to the manufacturer’si n s t r u c t i o n s .
Reaction efficiency was calculated by using serial 10-fold
dilutions of the housekeeping gene- b-actin and sample
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time PCR system (Applied Biosystems, Foster City, CA,
USA) and the thermal profile used was Stage 1: 50°C for
30 min; Stage 2: 95°C for 15 min; Stage 3: 94°C for 15
sec, 55°C for 30 sec; and 72°C for 30 sec, repeated for
30 cycles. Melting curve analysis was performed to ver-
ify product specificity. Reactions were performed in tri-
plicates. All quantitations (threshold cycle [CT] values)
were normalized to that of b-Actin to generate ΔCT,
and the difference between the ΔCT value of the sample
and that of the reference (uninfected sample) was calcu-
lated as ΔΔCT. The relative level of gene expression
was expressed as 2
-ΔΔCT. Primer sequences for the genes
of interest were designed using Primer Express 2.0 soft-
ware (Applied Biosystems, Foster City, CA, USA). The
primer sequences used in this study are as follows: JUN
FP 5′ TCGACATGGAGTCCCAGGA 3′; JUN RP 5′
GGCGATTCTCTCCAGCTTCC 3′; STAT1 FP
5′ CCATCCTTTGGTACAACATGC 3′; STAT1 RP 5′
TGCACATGGTGGAGTCAGG 3′; CXCL10 FP 5′
TTCAAGGAGTACCTCTCTCTAG 3′; CXCL10 RP
5′ CTGGATTCAGACATCTCTTCTC 3′; CCL5 FP 5′
TACCATGAAGGTCTCCGC 3′; CCL5 RP 5′GACAAA-
GACGACTGCTGG 3′; b-ACTIN FP 5′ CATGAAGTGT
GACGTGGACATCC 3′; b-A C T I NR P5′ GCTGATC-
CACATCTGGAAGG 3′; BCL2 FP 5′ GATGTCCAGC-
CAGCTGCACCTG 3′; BCL2 RP 5′ CACAAAGGC
ATCCCAGCCTCC 3′.
Results
Host gene expression response to HPAI-H5N1 (WB-
NIV2664) virus infection
The number of differentially expressed genes at different
time-points after WB-NIV2664 infection is given in
Table 1. Gene ontology analysis revealed that the genes
involved in immune responses, translation and apoptosis
were mostly up-regulated at all the time-points whereas
genes involved in cell cycle and transcription were
down-regulated. However, it was found that the number
of genes was quantitatively different between the differ-
ent time-points. A list of significantly up and down
regulated genes at different post infection time points
has been shown in Table S1 (Additional file 1). The
24 hpi time point showed maximum number of differ-
entially expressed genes.
Cluster analysis of the differentially expressed genes
was carried out using GENOWIZ software. K-means
clustering and hierarchical clustering methods resulted
in identification of 5 distinct patterns of gene expression
at different time-points (Figure 1). A total of 189 genes
were found common between all the time points.
Expression pattern of most of the apoptotic genes was
similar and formed a single cluster (Cluster 2 Figure 1).
Apoptotic genes BAX, BAK1, TRADD and CASP1 were
observed to be significantly up-regulated at 16 and 24
hpi but not at 4 and 8 hpi. Signaling molecules STAT1,
IL15RA, GNBP1 were found to be up-regulated at all
the time-points and showed a gradual increasing trend
from 4 hpi to 24 hpi. Genes coding for ribosomal pro-
teins and IRF1 (Interferon regulatory factor 1) were up-
r e g u l a t e da t4 ,8a n d1 6h p ib u td o w n - r e g u l a t e da t
24 hpi. Genes involved in cell cycle CDK4, CDK5,
C y c l i nE 1 ,C K N 2 B ,C D K N 2 Dw e r ed o w n - r e g u l a t e da t
all time-points post infection. Cytokines IL1, IL2-a
and chemokines CXCL10, CCL5 were specifically up-
regulated at 16 hpi.
Host gene expression response to RG modified H5N1
(IBCDC-RG7) virus infection
The differentially expressed genes in cells infected with
RG modified H5N1 (IBCDC-RG7) virus were involved in
similar biological processes (GO analysis) as in response
to H5N1 (WB-NIV2664) virus (Table 2). However, there
was significant quantitative difference between the
expression profiles of the two virus infections. Table S2
(Additional file 2) shows the list of significantly up and
Table 1 Summary of differentially expressed genes in response to infection with HPAI-H5N1 and RG modified H5N1 in
A549 cell lines
Time-
points
Genes qualifying the quality criteria in
replicated experiments
Differentially expressed genes
(+/-1.5folds, p < 0.05)
Up-regulated
genes
Down-regulated
genes
HPAI-H5N1 (A/Chicken/India/WB-NIV2664/2008)
4 h 253 40 15 25
8 h 208 24 13 11
16 h 254 101 53 48
24 h 309 111 53 58
RG Modified H5N1 (A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7)
4 h 262 60 36 24
8 h 212 128 67 61
16 h 237 109 58 51
24 h 305 42 22 20
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Page 3 of 11Figure 1 Hierarchical clustering (A) and k-means clustering (B) of differentially expressed genes of HPAI-H5N1 (A/Chicken/India/WB-
NIV2664/2008) infected A549 cells at different post-infection time points. Expression of genes with p < 0.05 and fold change > +/- 1.5
were considered as differentially expressed. Data presented are averaged gene expression changes for 2 different replicates for each time point.
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tion. Contrastingly, genes coding for ribosomal proteins
and other proteins involved in protein translation were
down-regulated at early stages of (4 hpi) IBCDC-RG7
infection as compared to WB-NIV2664. Cell cycle regula-
tor genes such as CDK5 and Cyclin B1 showed up-
regulation only at 4 hpi but not at 8, 16 and 24 hpi.
Apoptotic genes were significantly down-regulated at 16
hpi and 24 hpi. Genes involved in immune response such
as IRF1, IL15R-a, small inducible cytokine subfamily B
(Cys-X-Cys), IL1-b,M H C ,c l a s s 1 cw e r ed o w n - r e g u l a t e d
at 4 hpi and 16 hpi (Figure 2).
Table 2 Significantly enriched Gene Ontology terms in response to RG modified H5N1 and highly pathogenic H5N1
infection
GO Term (Biological processes) Gene Count P-value
RG modified H5N1 (A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7)
GO:0042981~regulation of apoptosis 45 4.45E-19
GO:0042127~regulation of cell proliferation 36 1.99E-12
GO:0043066~negative regulation of apoptosis 23 8.59E-11
GO:0043065~positive regulation of apoptosis 25 1.02E-10
GO:0051726~regulation of cell cycle 21 1.09E-09
GO:0006468~protein amino acid phosphorylation 28 7.60E-09
GO:0045859~regulation of protein kinase activity 19 7.55E-08
GO:0019221~cytokine-mediated signaling pathway 10 9.14E-08
GO:0016477~cell migration 16 5.87E-07
GO:0000086~G2/M transition of mitotic cell cycle 6 3.15E-06
GO:0051384~response to glucocorticoid stimulus 8 2.90E-05
GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade 9 2.96E-05
GO:0034330~cell junction organization 7 4.44E-05
GO:0006260~DNA replication 11 6.29E-05
GO:0046649~lymphocyte activation 11 9.26E-05
GO:0045321~leukocyte activation 12 1.01E-04
HPAI-H5N1 (A/Chicken/India/WB-NIV2664/2008)
GO:0042981~regulation of apoptosis 29 1.35E-13
GO:0042127~regulation of cell proliferation 26 2.83E-11
GO:0043066~negative regulation of apoptosis 17 1.27E-09
GO:0006954~inflammatory response 15 2.81E-08
GO:0045597~positive regulation of cell differentiation 13 3.55E-08
GO:0043065~positive regulation of apoptosis 16 1.38E-07
GO:0001932~regulation of protein amino acid phosphorylation 11 2.14E-07
GO:0006952~defense response 18 5.11E-07
GO:0045321~leukocyte activation 12 5.73E-07
GO:0006979~response to oxidative stress 10 1.38E-06
GO:0010740~positive regulation of protein kinase cascade 10 1.61E-06
GO:0051726~regulation of cell cycle 13 1.87E-06
GO:0030098~lymphocyte differentiation 8 5.38E-06
GO:0046649~lymphocyte activation 10 6.80E-06
GO:0019221~cytokine-mediated signaling pathway 7 6.83E-06
GO:0048534~hemopoietic or lymphoid organ development 11 8.57E-06
GO:0006955~immune response 17 1.10E-05
GO:0030595~leukocyte chemotaxis 5 1.02E-04
GO:0042113~B cell activation 6 1.48E-04
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between HPAI-H5N1 and RG modified H5N1 virus
infections
Gene expression data was compared separately at each
post infection time points between the two virus
infections (Figure 3). Significantly higher numbers of dif-
ferentially expressed genes were observed at 16 hpi (Fig-
ure 3). A total of 44 genes were found to be common
between the two virus infections at 16 hpi. Out of them 8
genes were up-regulated and 8 genes were down-
Figure 2 Hierarchical clustering (A) and k-means clustering (B) of differentially expressed genes of RG modified H5N1 (A/India/NIV/
2006(H5N1)-PR8-IBCDC-RG7) infected A549 cells at different post-infection time points. Expression of genes with p < 0.05 and fold
change > +/- 1.5 were considered as differentially expressed. Data presented are averaged gene expression changes for 2 different replicates.
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Page 6 of 11Figure 3 Comparative analysis of gene expression changes between HPAI-H5N1 (A/Chicken/India/WB-NIV2664/2008) and RG modified
H5N1 (A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7) infected A549 cell lines at different post-infected time points. Venn-diagram showing
the common genes between highly-pathogenic and RG modified H5N1 infected A549 cells at A. 4 hpi time point B. 8 hpi time point C. 16 hpi
time point D. 24 hpi time point.
Table 3 Genes showing contrasting expression pattern between HPAI-H5N1 and RG modified H5N1 virus infection in
A549 cells at 16 hpi
GENES HPAI-H5N1 (A/Chicken/India/WB-NIV2664/2008) RG modified H5N1(A/India/NIV/2006(H5N1)-PR8-IBCDC-RG7)
IL2R-alpha 1.5 -1.5
CXCL10 4.0 -3.0
CCL5(RANTES) 2.0 -2.0
IL1-alpha 2.0 -2.0
IL15R-alpha 2.6 -2.8
JUN 2.0 -2.8
STAT1 3.2 -2.0
FAS 2.0 -2.0
CyclinB1 -2.0 2.0
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Page 7 of 11regulated in response to both the virus infections. How-
ever, 28 genes were found to have differential expression
pattern and were mainly involved in Cytokine-cytokine
receptor interaction, Toll like-receptor mediated signal-
ing and p53 signaling pathway [Figure S1 (Additional file
3) and Figure S2 (Additional file 4)]. Cytokines - CXCL10
and RANTES were up-regulated by 4 and 2 folds respec-
tively in WB-NIV2664 infected cells but were down-
regulated by 3 and 2 folds respectively in response to
infection with IBCDC-RG7 (Table 3). Transcription fac-
tors v-JUN and NF-B were up-regulated in response to
WB-NIV2664 infection but were down-regulated in
infection with recombinant RG modified H5N1 (Table
3). STAT1, which plays a significant role in JAK-STAT
signaling pathway and has been reported to be involved
in host immune response to virus infections, was found
to be differentially expressing between the two virus
infections in our study. Surprisingly, cell cycle regulator
Cyclin B1 was down-regulated in WB-NIV2664 infected
cells but up-regulated in IBCDC-RG7 infected cells.
Pathway analysis using KEGG [Kyoto Encyclopedia of
genes and genome http://www.genome.jp/kegg/] tool
reveled that these differences in expression profile
between cells infected with two virus strains could mani-
fest into differential cell cycle progression and immune
response. Expression of selected genes was validated
using Real-time PCR, which correlated with the microar-
ray results (Figure 4).
Discussion
The present study demonstrates that the host gene
expression responses to the highly pathogenic and
recombinant H5N1 viruses were qualitatively similar but
quantitatively different. The different time points of
virus infection or different stages of virus life cycle
played an important role in the host gene expression
responses. Maximum differences in the host gene
expression profile in response to both the virus infec-
tions were observed at 16 hpi. This time point is impor-
tant because at this stage large number of completely
assembled virus progeny particles inside the cells give
rise to increased host immune responses [17].
Figure 4 Validation of microarray data by real time PCR. Genes showing differential expression between HPAI-H5N1(HP) and RG modified
H5N1(LP) virus infections at 16 hpi in A549 were selectively taken for RT-PCR analysis. The expressions of these genes were found to be
matching with the microarray analysis.
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Page 8 of 11Figure 5 A model depicting a probable cellular response to HPAI-H5N1 virus infection in A549 cells which are not activated in
response to RG modified H5N1 virus infection. Influenza virus infection results in activation of various signaling events in the host cells. In
response to HPAI-H5N1 infection, Toll-like receptor (TLR) mediated signaling events result in activation of inflammatory cytokines like CXCL10,
CCL5 through activation of specific transcription factors like NF-B and v-JUN, as observed in our study. However, this mechanism does not get
activated in response to RG modified H5N1 as evident by the down-regulation of cytokine genes. The transcription factors like NF-B and JUN
were also found to be down-regulated during RG modified H5N1 infection.
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genes between the two infections were found at 16 hpi.
It was interesting to observe significant increase in the
expression of many cytokines and transcription factors
in response to H5N1 (WB-NIV2664) virus infection but
decrease in the expression of same genes in infection
with RG modified H5N1 (IBCDC-RG7) at 16 hpi. These
cytokines which mainly included IL2, IL1, CXCL10 and
RANTES were reported to be involved in cytokine-
storm in response to viral infection in humans [18,19]
and thus associated with H5N1 virulence.
In spite of overall similar cellular responses in both
the infections, WB-NIV2664 was found to be a compel-
ling inducer of cytokines CXCL10 and RANTES than
IBCDC-RG-7. This differential expression of cytokines
could result in a totally different host cellular response
to both the virus infections. A hypothetical model show-
ing probable cellular response to HPAI-H5N1 infection
has been shown in figure 5. This type of signaling events
might not get activated during RG modified H5N1
infection.
Differential expression of STAT1 in the two virus
infections observed in our study also indicate higher
cytokine mediated inflammatory responses in WB-
NIV2664 infection than the modified strain [20]. IRF-1
has been shown to activate STAT1 and regulates TNF-
related apoptosis-inducing ligand (TRAIL) in HIV-1-
infected macrophages [21]. The up- regulation of
STAT1 in our experiments could be due to IRF1
mediated signaling. Up-regulation of NF-Ba n dv - J U N
observed in this study in response to WB-NIV2664
infection may provide necessary signals required for bet-
ter virus entry and synthesis of viral proteins inside the
cells [22,23].
Cytokine dysregulation plays a major role in pathogen-
esis of influenza A (H5N1) viruses [5]. Studies on ferrets
and nonhuman primates [11,24] as well as on human
macrophages [10] have clearly demonstrated the
increased cytokine response during H5N1 infection.
The differences in the constitution of the internal
genes between the subtypes of influenza viruses may
p o s s i b l yp l a ya ni m p o r t a n tr o l ei nd i f f e r e n t i a lh o s tg e n e
expression responses. Internal genes of H5N1 viruses,
like non structural (NS1) and polymerase basic protein
2 (PB2) have been correlated with host immune
responses and high pathogenicity [4,25]. Moreover, it is
well established that presence of multiple basic amino
acids in the cleavage site of HA is critical for high
pathogenicity and systemic spread of H5N1 viruses [4].
Replacement of six internal genes with A/PR/8/34 and
absence of multibasic amino acids at the HA cleavage
site of IBCDC-RG7, could be a vital reason for its inabil-
ity to induce host cytokine response similar to WB-
NIV2664. Hence, our data supports that these host
responses are probably driven by intrinsic differences of
gene constitution of the H5N1 viruses.
Up-regulation of apoptotic genes like BAX, BAK1 in
H5N1 (WB-NIV2664) but not in IBCDC-RG7 infection
could be a part of cytokine mediated response [26]. The
higher expression of apoptotic genes could explain
higher amount of tissue damage observed in other stu-
dies during H5N1 infection. Among various viral factors,
NS1 has been reported earlier to induce caspase-depen-
dent apoptosis in human alveolar basal epithelial cells
[25]. NS1 protein of H5N1 might have a role in enhan-
cing expression of apoptotic factors leading to high
virulence.
Conclusion
Thus, our findings show that HPAI-H5N1 is a better
inducer of inflammation and cytokine mediated apopto-
sis compared to the RG modified H5N1 at a very speci-
fic stage of infection (16 hpi) which could explain its
high pathogenicity. This study highlights the role played
by the viral factors in inducing host defense mechanism
by modulating host gene expression response.
Additional material
Additional file 1: Table S1. List of significantly up-regulated and
down-regulated genes in A549 cells infected with HPAI-H5N1 at
different post-infection time points. Genes showing increase or
decrease in expression by ≥ 1.5 folds (Significant, p-value < 0.05)
compared to controls at different post infection time points studied with
HPAI-H5N1 have been enlisted.
Additional file 2: Table S2. List of significantly up- and down-
regulated genes in A549 cell lines infected with RG modified H5N1
at different post-infection time points. Genes showing increase or
decrease in expression by ≥ 1.5 folds (Significant, p-value < 0.05)
compared to controls at different post infection time points studied with
RG modified H5N1 have been enlisted.
Additional file 3: Figure S1. Genes involved in chemokine &
cytokine mediated signaling in highly-pathogenic and RG modified
H5N1 infected A549 cell lines (16 h post infection time point).R e d
arrow indicates expression in highly-pathogenic H5N1 infected A549 cells
and Blue arrow indicates expression in RG modified H5N1 infected A549
cells. Up- arrow indicates up-regulation and down-arrow indicates down-
regulation.
Additional file 4: Figure S2. Genes involved in p53 signaling
pathway in highly-pathogenic and RG modified H5N1 infected
A549 cell lines (16 h post infection time point). Red arrow indicates
expression in highly-pathogenic H5N1 infected A549 cells and Blue arrow
indicates expression in RG modified H5N1 infected A549 cells. Up- arrow
indicates up-regulation and down-arrow indicates down-regulation.
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GO: (gene ontology)
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